Trial NCT02807454

View at ClinicalTrials.gov 
Org. Study IDs: MEDI4736-MM-003

Last trial update was posted on 2023-02-21

MeSH Interventions

Daratumumab Dexamethasone Durvalumab Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Health Authority request due to class effect

Limitations And Caveats

This study stopped enrolling participants on 05-Sep-2017 and was terminated earlier than planned on 03-Jan-2022. This results disclosure report provides outputs from the Simon Stage 1: D2 and PD3 arms. Simon Stage 2: D2 did not enroll any participants.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID